CURX vs KHC · $8.9M cap vs P/E 12, rev $12.31B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus Kraft Heinz Co (KHC) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
Kraft Heinz Co (KHC) is a packaged foods company listed on US.
CURX does not have a complete income-statement cache yet.
Latest reported KHC revenue for 2026-06-27 was $12.31B. Net income was -$4.66B. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
CURX currently screens at market cap $8.9M. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
Not investment advice. Open the CURX and KHC stock pages for the full models.
Not investment advice.